Introduction
The North Lisbon University Hospital Center (CHULN) is one of the main hospitals of the Portuguese National Health Service (SNS), and results from the merge of two important public University Hospitals, Santa Maria Hospital and Pulido Valente Hospital.
CHULN has considerable assets in human resources, applied technologies and in accumulated know-how along with the support it renders to the populations from its area of direct influence, and with the guarantee of a differentiated referencial response in multiple clinical areas, both national and internationally, including in the Portuguese-speaking African Countries (the “PALOP”).
By the end of 2020, the North Lisbon University Hospital Center had a total of 6.538 professionals, with over 1400 medical doctors, distributed across 11 Clinical Departments and 42 Clinical Units.
General Surgery
Heart and Vessels
Cardio-thoracic Surgery
Vascular Surgery
Surgical Specialities
Otorhinolaringology
Ophthalmology
Plastic Surgery
Stomatology
Orthopedy
Urology
Medical Specialities
Dermatology
Infeccious Diseases
Endocrinology
Gastroenterology
Immuno-allergology
Medicine
Nephrology
Rheumatology
Compl. Diag. and Therapeutics
Histopathology
Radiology
Neurological radiology
Immuno-hemotherapy
Physical Med. & Rehabilitation
Laboratory Medicine
Neurosciences & Mental Health
Neurology
Neurosurgery
Psychiatry & Mental Health
Obstetrics, Gynecology and Reprod. Medicine
Obstetrics
Gynecology
Oncology
Hematology
Oncology
Radiotherapy
Pediatrics
Pediatric Surgery
Genetics
Pediatric Cardiology
Neonatology
Pediatrics
Pediatric Psychiatry
Thorax
Thoracic Surgery
Emergency & Intensive Care Medicine
Central Emergency
Contact Details
Innovation Department
Hospital Administration
Clinical Investigation Centre
Activity 2020
Appointments
Hospital beds
Surgical procedures
Emergency admissions
Sessions in day care
Appointments per day
Inpatients
Admissions per day
Patients treated in day care sessions
Deliveries
Ambulatorization of elective procedures
Medical exams
Records of patient data
Lisbon Medical Academic Centre (CAML)
The LMCA integrates the three pillars of the Healthcare Innovation triangle, CHULN, iMM and the Faculty of Medicine.
The Faculty of Medicine of the University of Lisbon (FMUL) is an institution of higher education integrated in the Classical University of Lisbon.
The Institute of Molecular Medicine (iMM) is considered one of the leading institutes of biomedical research in the country. It is associated to the Ministry of Science, Technology and Higher Education.
CAML’s differentiated structure allows for the promotion and development of the academic dimension and qualification of clinical practice, the modernization and development of research, medical education and innovation of the health sciences in pre- and post-graduation.
National Reference Centers
Transplantation
Adults renal transplantation
Pediatrics renal tranplantation
Medical and Surgical Area
Structural intervention Cardiology
Congenital heart disease
Rare Diseases
Familiar paramyloidosis
Rare diseases - Hereditary diseases of metabolism
Refractory epilepsy
Congenital coagulopathies
Cystic fibrosis
Procedures
ECMO
Cochlear implants
Interventional Neuroradiology in Cerebrovascular disease
Oncology
Pediatric Oncology – CNS cancer
Adult Oncology - esophageal cancer
Adult Oncology – bone and soft tissues sarcomas
Adult Oncology - rectal cancer
Adult Oncology - hepatobiliary / pancreatic cancer
Clinical Investigation
Clinical Investigation Centre of Lisbon's Academic Medical Centre - CIC-CAML is a Clinical Research Center which aims to centralize all the clinical research management and activities in a recent infrastructure dedicated exclusively to the development and support of clinical trials.
As a Clinical Research Center (CRC), CIC-CAML has dedicated facilities to perform clinical research according to ICH-GCP Guidelines providing to the clinical investigators the necessary infrastructure and services for the support and conduct of high quality clinical trials, from Phase I to IV. CIC-CAML as an infrastructure devoted to centralize clinical research support with a management team including study coordinators and study-nurse staff, allowing enrolment of patients.
At the moment we are involved in more than 180 clinical trials (3 are phase I) and had more than 150 patients included in clinical trials in different therapeutic areas such as: Oncology, Rheumatology, Neurology and Pediatrics. We also conduct observational studies and some of these projects are investigator-initiated studies.
European Reference Networks
European Reference Networks (ERNs) involve more than 900 highly specialised health care teams, located in more than 300 hospitals in 26 European countries.
The main mission of the ERNs is to help patients with rare or low-prevalence complex diseases. CHULN is an active member of the following ERNs. In addition, at the European level CHLUN is also an Associate Partner of InnoSTARS, EIT Health.
Pediatrics
Hereditary Metabolic Disorders – MetabERN
MetabERN I Amino and organic acid related disorders (AOA)
MetabERN I Carbohydrate, fatty acid oxidation and ketone bodies disorder (C-FAO)
MetabERN I Lysosomal storage disorders (LSD)
Pediatric transplantation of the kidney – ERN TRANSCHILD
Oncology
Adult Oncology - esophageal cancer
Adult Oncology – bone and soft tissues sarcomas
Adult Oncology - rectal cancer
Adult Oncology - hepatobiliary / pancreatic cancer
Neurosciences
Rare craniofacial anomalies and ENT disorders – ERN CRANIO
Refractory epilepsy I Epilepsy – ERN EpiCARE
Cardiology
Structural intervention Cardiology
Hematology
Graft versus host disease after hematopoietic progenitor
Transplantation - Euro GVHD
Reumatology and Bone Met.
Connective tissue and Musculoskeletal Diseases – ERN ReCONNET
